Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor survival rates and frequently carries oncogenic KRAS mutation. However, KRAS has thus far not been a viable therapeutic target. We found that the abundance of YAP mRNA, which encodes Yes-associated protein (YAP), a protein reg...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Zhang, Weiying, Nandakumar, Nivedita, Shi, Yuhao, Manzano, Mark, Smith, Alias, Graham, Garrett, Gupta, Swati, Vietsch, Eveline E., Laughlin, Sean Z., Wadhwa, Mandheer, Chetram, Mahandranauth, Joshi, Mrinmayi, Wang, Fen, Kallakury, Bhaskar, Toretsky, Jeffrey, Wellstein, Anton, Yi, Chunling
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4175524/
https://ncbi.nlm.nih.gov/pubmed/24803537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.2005049
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים